Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of all global deaths. It can be associated, in some cases, with multiple organ failure and cytokine storm. The main objective of this study is to estimate and to compare the activation rate of the Nucleotide-binding domain Leucine Rich repeat containing Protein 3 (NLRP3) inflammasome in platelets between five groups of patients suffering from bacterial and/or viral sepsis, with different severity levels according to Sequential Organ Failure Assessment (SOFA) score to precise the platelets' implication in this cytokine storm.

Who May Be Eligible (Plain English)

Who May Qualify: - For all groups: patients older than 18 years at inclusion and acceptation of participation by the patient, his relative or his legal representative (depending on the situation) - For groups 1, 2, 3 and 5: Patient with a confirmed sepsis (microbiological confirmation) - For group 4 : Patient non infected Who Should NOT Join This Trial: - Refusal of participation by the patient, his relative or his legal representative (depending on the situation) - Patients subject to a safeguard measure of justice - Patients younger than 18 years at inclusion Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * For all groups: patients older than 18 years at inclusion and acceptation of participation by the patient, his relative or his legal representative (depending on the situation) * For groups 1, 2, 3 and 5: Patient with a confirmed sepsis (microbiological confirmation) * For group 4 : Patient non infected Exclusion Criteria: * Refusal of participation by the patient, his relative or his legal representative (depending on the situation) * Patients subject to a safeguard measure of justice * Patients younger than 18 years at inclusion

Locations (1)

Centre Hospitalier Universitaire de la Guadeloup
Les Abymes, Guadeloupe, Guadeloupe